Lee Michael S, Fong Scott, Owens Jade S, Mahatme Ronak J, Kim David N, Gillinov Stephen M, Moran Jay, Simington Jacquelyn, Islam Wasif, Abu Seyi, Jimenez Andrew E
Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Advanced Orthopaedics & Sports Medicine, San Francisco, California, USA.
Orthop J Sports Med. 2023 Apr 25;11(4):23259671231160559. doi: 10.1177/23259671231160559. eCollection 2023 Apr.
Despite several studies' reports on outcomes of concomitant hip arthroscopy and periacetabular osteotomy (PAO), there is a paucity of aggregate data in the literature.
To evaluate outcomes and survivorship after concomitant hip arthroscopy and PAO.
Systematic review; Level of evidence, 4.
The PubMed, Cochrane, and Scopus databases were searched in April 2022 using the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. The following keywords were used: (hip OR femoroacetabular impingement) AND (arthroscopy OR arthroscopic) AND (periacetabular osteotomy or rotational osteotomy) AND (outcomes OR follow-up). Of 270 articles initially identified, 10 studies were ultimately included. The following information was recorded for each study if available: publication information; study design; study period; patient characteristics; follow-up time; indications for hip arthroscopy; patient-reported outcomes (PROs); rates of secondary hip preservation surgeries; and rates of conversion to total hip arthroplasty (THA). Survivorship was defined as nonconversion to THA.
The study periods for the 10 included articles ranged from 2001 to 2018. Three studies were level 3 evidence, and 7 studies were level 4 evidence. This review included 553 hips with a mean follow-up of 1 to 12.8 years. All 10 studies listed dysplasia as an indication for surgery. Of 9 studies that reported PRO scores, 7 reported significant improvement after surgery. Studies with a <5-year follow-up reported conversion to THA rates of 0% to 3.4% and overall secondary surgery rates of 0% to 10.3%. Similarly, studies with >5-year follow-up reported conversion to THA rates of 0% to 3% and overall secondary surgery rates of 0% to 10%.
Patients who underwent concomitant hip arthroscopy and PAO reported favorable outcomes, with 7 of the 9 studies that provided PRO scores indicating significant preoperative to postoperative improvement.
尽管有多项研究报告了髋关节镜检查与髋臼周围截骨术（PAO）联合手术的结果，但文献中汇总数据较少。
评估髋关节镜检查与PAO联合手术后的结果及生存率。
系统评价；证据等级，4级。
按照PRISMA（系统评价和Meta分析的首选报告项目）指南，于2022年4月检索了PubMed、Cochrane和Scopus数据库。使用了以下关键词：（髋关节或股骨髋臼撞击症）AND（关节镜检查或关节镜的）AND（髋臼周围截骨术或旋转截骨术）AND（结果或随访）。在最初识别的270篇文章中，最终纳入了10项研究。若有可用信息，为每项研究记录以下内容：发表信息；研究设计；研究时间段；患者特征；随访时间；髋关节镜检查的适应证；患者报告的结果（PROs）；二次髋关节保留手术率；以及全髋关节置换术（THA）转换率。生存率定义为未转换为THA。
纳入的10篇文章的研究时间段为2001年至2018年。3项研究为3级证据，7项研究为4级证据。本综述纳入了553个髋关节，平均随访时间为1至12.8年。所有10项研究均将发育异常列为手术适应证。在报告PRO评分的9项研究中，7项报告术后有显著改善。随访时间<5年的研究报告THA转换率为0%至3.4%，总体二次手术率为0%至10.3%。同样，随访时间>5年的研究报告THA转换率为0%至3%，总体二次手术率为0%至10%。
接受髋关节镜检查与PAO联合手术的患者报告了良好的结果，在提供PRO评分的9项研究中，有7项表明术前至术后有显著改善。
